Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7576 |
Intermediate Similarity |
NPD1730 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD9084 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD214 |
Approved |
0.7069 |
Intermediate Similarity |
NPD213 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD5682 |
Phase 3 |
0.6949 |
Remote Similarity |
NPD220 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD219 |
Phase 3 |
0.6949 |
Remote Similarity |
NPD216 |
Approved |
0.6949 |
Remote Similarity |
NPD217 |
Approved |
0.6949 |
Remote Similarity |
NPD218 |
Approved |
0.6807 |
Remote Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD1058 |
Discontinued |
0.6685 |
Remote Similarity |
NPD247 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4054 |
Clinical (unspecified phase) |
0.6497 |
Remote Similarity |
NPD4182 |
Phase 3 |
0.6497 |
Remote Similarity |
NPD4183 |
Phase 3 |
0.6471 |
Remote Similarity |
NPD2647 |
Phase 3 |
0.6429 |
Remote Similarity |
NPD248 |
Discontinued |
0.6393 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.6369 |
Remote Similarity |
NPD4709 |
Approved |
0.6333 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6319 |
Remote Similarity |
NPD3107 |
Discontinued |
0.6304 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6304 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.6303 |
Remote Similarity |
NPD8830 |
Phase 3 |
0.6243 |
Remote Similarity |
NPD8121 |
Phase 3 |
0.6243 |
Remote Similarity |
NPD8120 |
Approved |
0.6218 |
Remote Similarity |
NPD5666 |
Phase 2 |
0.6213 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.617 |
Remote Similarity |
NPD3083 |
Approved |
0.6145 |
Remote Similarity |
NPD250 |
Approved |
0.6145 |
Remote Similarity |
NPD249 |
Approved |
0.6145 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.6141 |
Remote Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.6099 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.6089 |
Remote Similarity |
NPD4240 |
Approved |
0.6089 |
Remote Similarity |
NPD1572 |
Phase 2 |
0.6082 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.6077 |
Remote Similarity |
NPD195 |
Approved |
0.6077 |
Remote Similarity |
NPD186 |
Discovery |
0.6073 |
Remote Similarity |
NPD1777 |
Approved |
0.6073 |
Remote Similarity |
NPD1776 |
Approved |
0.6064 |
Remote Similarity |
NPD5321 |
Phase 3 |
0.6054 |
Remote Similarity |
NPD1369 |
Phase 2 |
0.6043 |
Remote Similarity |
NPD1732 |
Phase 3 |
0.6034 |
Remote Similarity |
NPD185 |
Approved |
0.6033 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.6032 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6011 |
Remote Similarity |
NPD193 |
Suspended |
0.6 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.5967 |
Remote Similarity |
NPD166 |
Approved |
0.5965 |
Remote Similarity |
NPD1775 |
Approved |
0.5965 |
Remote Similarity |
NPD1085 |
Approved |
0.5956 |
Remote Similarity |
NPD1571 |
Phase 2 |
0.5946 |
Remote Similarity |
NPD283 |
Approved |
0.5941 |
Remote Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.5936 |
Remote Similarity |
NPD339 |
Approved |
0.5922 |
Remote Similarity |
NPD3696 |
Approved |
0.5922 |
Remote Similarity |
NPD3695 |
Approved |
0.5907 |
Remote Similarity |
NPD7988 |
Suspended |
0.5904 |
Remote Similarity |
NPD169 |
Phase 2 |
0.5889 |
Remote Similarity |
NPD2253 |
Discontinued |
0.5886 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.5882 |
Remote Similarity |
NPD338 |
Approved |
0.5882 |
Remote Similarity |
NPD242 |
Approved |
0.5872 |
Remote Similarity |
NPD9366 |
Approved |
0.5856 |
Remote Similarity |
NPD2179 |
Discontinued |
0.585 |
Remote Similarity |
NPD4716 |
Approved |
0.5841 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.5821 |
Remote Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.5815 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.5797 |
Remote Similarity |
NPD3431 |
Approved |
0.5797 |
Remote Similarity |
NPD3430 |
Approved |
0.5795 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.5794 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.5789 |
Remote Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.5765 |
Remote Similarity |
NPD2221 |
Clinical (unspecified phase) |
0.5764 |
Remote Similarity |
NPD1692 |
Approved |
0.5759 |
Remote Similarity |
NPD8030 |
Approved |
0.5758 |
Remote Similarity |
NPD4089 |
Clinical (unspecified phase) |
0.574 |
Remote Similarity |
NPD307 |
Approved |
0.5735 |
Remote Similarity |
NPD5885 |
Approved |
0.573 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.5722 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.5714 |
Remote Similarity |
NPD6521 |
Phase 3 |
0.5714 |
Remote Similarity |
NPD6520 |
Phase 3 |
0.5714 |
Remote Similarity |
NPD5827 |
Discontinued |
0.5707 |
Remote Similarity |
NPD5969 |
Clinical (unspecified phase) |
0.57 |
Remote Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.5699 |
Remote Similarity |
NPD775 |
Approved |
0.5685 |
Remote Similarity |
NPD3811 |
Discontinued |
0.5683 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.568 |
Remote Similarity |
NPD578 |
Discontinued |
0.5678 |
Remote Similarity |
NPD3081 |
Clinical (unspecified phase) |
0.5668 |
Remote Similarity |
NPD796 |
Phase 2 |
0.5665 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.5665 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.5659 |
Remote Similarity |
NPD4765 |
Approved |
0.5659 |
Remote Similarity |
NPD4764 |
Approved |
0.5657 |
Remote Similarity |
NPD1127 |
Approved |
0.5657 |
Remote Similarity |
NPD1128 |
Approved |
0.565 |
Remote Similarity |
NPD282 |
Approved |
0.5648 |
Remote Similarity |
NPD7103 |
Approved |
0.5647 |
Remote Similarity |
NPD580 |
Discontinued |
0.5632 |
Remote Similarity |
NPD281 |
Approved |
0.5622 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.5622 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.5617 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.5611 |
Remote Similarity |
NPD1120 |
Approved |
0.5611 |
Remote Similarity |
NPD1121 |
Approved |
0.5604
|
Remote Similarity |
NPD7138 |
Phase 2 |